Health - Google News: FDA panel to weigh heart safety of Novo's new insulin - Reuters

Health - Google News Google News

FDA panel to weigh heart safety of Novo's new insulin - Reuters Oct 25th 2012, 17:57 FDA panel to weigh heart safety of Novo's new insulin Reuters LONDON (Reuters) - A U.S. expert panel assessing Novo Nordisk's ultra long-acting insulin, degludec, will study its heart safety, raising a potential obstacle to approval in the world's top market. The panel will meet November 8 to focus on the issue, "as ... Novo Nordisk A/S: FDA Discloses Focus of Advisory Committee Meeting on ...MarketWatch (press release) all 18 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: